CMS Changes Competitive Bid Program Impacting Contracts and Bid Submission Requirements for Financial Documentation – What Providers Need to Know

Published in Government Relations on January 09, 2026

The Centers for Medicare and Medicaid Services’ (CMS) changes to the DMEPOS Competitive Bid Program as outlined in CMS-1828-F will reshape how suppliers prepare bids, qualify for contracts, and manage operational readiness. For DME suppliers, understanding both the changes to the contract awards and the bid submission is essential to understanding and preparing for the next bidding cycle. 

Changes to Financial Documentation Required for Bid Submission 

One of the most consequential updates for suppliers is the dramatic simplification of required financial documentation during bid submission. Under the updated Competitive Bidding Program (CBP), CMS will no longer require certain financial documents, including tax returns, income statements, balance sheets, and cash flow statements. All CMS will require in the next round is a business credit report with a numerical score or rating. If no numerical score exists, suppliers must instead submit a business credit report showing insufficient data, and a personal credit report for the Authorized or Delegated Official listed in PECOS. 

CMS will provide detailed information regarding the credit report and numerical credit score and/or rating requirements for entity types in the Request for Bids Instructions, which will be published prior to the opening of the bid window for each round of the DMEPOS CBP. 

Suppliers should note that Bid Surety Bonds are still required for the next round. 

Changes to CBP Contract Awards  

In addition to the changes to the financial documentation required to submit a bid, CMS has also made significant updates to the required number of contracts per category per RID CBP area and how they will determine the number of required contracts needed.

One major departure from the previous CBP is the change to allow CMS the discretion to decrease contract awards to a minimum of two contracts per product category per RID CBP area, down from the prior minimum of five contracts.  

CMS will also now rely on the most recent year’s utilization data (likely 2025 or 2026) to determine the number of contracts needed instead of supplier reported capacity. The number of contracts offered for each product category will be based on 125% of the number of suppliers furnishing at least 3% of total national allowed services for the lead item in 2025. So, for example, if eight suppliers account for 3% of utilization for a lead item, CMS may award contracts to approximately 10 suppliers (8 × 125%).  

Notably, where previously there were between 500-1000+ suppliers who were able to provide products to Medicare patients across the country, under the new CBP, there could be as few as 5-10 providers in the country who would win bids for a given category.

Though the above is concerning, the Final Rule continues to have a small supplier target stating that if fewer than 30% of winning suppliers qualify as small businesses (≤ $3.5M in annual revenue), CMS may award additional contracts to meet this benchmark.  

Supplier Considerations Due to Program Changes 

The decrease in required contracts along with the regional or nationwide RID CBP fundamentally alters the competitive dynamics for providers. 

Under a nationwide or regional RID CBP, suppliers are required to furnish items across the entire CBP regardless of where the patient lives. In order to be awarded a contract, suppliers must hold all applicable state and federal licenses in each state covered by the competitive bidding area to win a contract. Suppliers expecting to bid in the next round are encouraged to start preparing now due to the lengthy licensure process. 

However, suppliers should also exercise caution in any business decision that may negatively impact the business or personal credit report. With CMS no longer considering financial statements, the business credit report becomes the primary determinant of financial stability. Suppliers are encouraged to strengthen their credit worthiness and be mindful of any action taken that may impact their business or personal credit report. 

Questions? 

Find the Final Rule, CMS Fact Sheet, and other resources on VGM’s Competitive Bidding Resource Page and van Halem Group - Competitive Bidding Program

Further Reading About the Competitive Bidding Program: 

From Our Experts

VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention.